Arkeon, a Vienna, Austria-based ingredients company converting CO2 directly into protein ingredients, raised €2.7M in funding.
The round was led by ICL.
The company intends to use the funds to support its innovative and sustainable one-step fermentation bioprocess, which creates completely customizable protein ingredients by capturing the greenhouse gas carbon dioxide (CO2) and converting it into the 20 proteinogenic amino acids necessary for human nutrition.
Co-Founded by Dr. Simon Rittmann, Dr. Guenther Bochmann, and Dr. Gregor Tegl, Arkeon is an ingredients company leveraging microbes to convert CO2 directly into protein ingredients. Its patented process pioneered the harnessing of carbon dioxide to make protein – through the use of archaea, a highly resilient single-celled microorganism – without genetic engineering. Archaea, part of the microbiota of all organisms, naturally feeds on CO2 and transforms these environmental emissions into nutritious protein – meaning the process is sustainable and regenerative. The company’s proprietary technology is a new, innovative approach to produce amino acids and functional peptides for food and lifestyle products, enabling a regenerative way to nourish people on a global scale.
FinSMEs
19/01/2023